Clinical Trial Update: Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 trial investigating a dexamethasone-sparing approach including NEPA for chemotherapy-induced nausea and vomiting due to cisplatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• NEPA (netupitant/palonosetron)
• dexamethasone-sparing approach

Snippet

Sponsor: Consorzio Oncotech | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: UNKNOWN